134 related articles for article (PubMed ID: 2103330)
1. Metabolism and mutagenicity of dibenzo[a,e]pyrene and the very potent environmental carcinogen dibenzo[a,l]pyrene.
Devanesan PD; Cremonesi P; Nunnally JE; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1990; 3(6):580-6. PubMed ID: 2103330
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
3. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland.
Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S
Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274
[TBL] [Abstract][Full Text] [Related]
4. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
5. Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a, l]pyrene.
Cavalieri EL; Rogan EG; Higginbotham S; Cremonesi P; Salmasi S
J Cancer Res Clin Oncol; 1989; 115(1):67-72. PubMed ID: 2921274
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
Hughes MF; Kadry AR; Gairola CG; Flesher JW
Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
[TBL] [Abstract][Full Text] [Related]
7. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
[TBL] [Abstract][Full Text] [Related]
8. Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland.
Todorovic R; Devanesan P; Rogan E; Cavalieri E
Chem Res Toxicol; 2005 Jun; 18(6):984-90. PubMed ID: 15962933
[TBL] [Abstract][Full Text] [Related]
9. Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.
Platt KL; Degenhardt C; Grupe S; Frank H; Seidel A
Chem Res Toxicol; 2002 Mar; 15(3):332-42. PubMed ID: 11896680
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1986 Nov; 7(11):1837-44. PubMed ID: 3769131
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro metabolism, cell transformation, mutagenicity, and DNA adduction of dibenzo[c,mno]chrysene.
Desai D; Sharma AK; Lin JM; Krzeminski J; Pimentel M; El-Bayoumy K; Nesnow S; Amin S
Chem Res Toxicol; 2002 Jul; 15(7):964-71. PubMed ID: 12119008
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene.
Luch A; Platt KL; Seidel A
Carcinogenesis; 1998 Apr; 19(4):639-48. PubMed ID: 9600349
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of C24H14 PAH in human cells expressing CYP1A1.
Durant JL; Lafleur AL; Busby WF; Donhoffner LL; Penman BW; Crespi CL
Mutat Res; 1999 Oct; 446(1):1-14. PubMed ID: 10613181
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
Chiu PL; Yang SK
Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
Luch A; Seidel A; Glatt H; Platt KL
Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene.
Luch A; Glatt H; Platt KL; Oesch F; Seidel A
Carcinogenesis; 1994 Nov; 15(11):2507-16. PubMed ID: 7955100
[TBL] [Abstract][Full Text] [Related]
19. Multiple metabolic pathways for the mutagenic activation of 3-nitrobenzo[a]pyrene.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1985 Aug; 6(8):1235-8. PubMed ID: 3893788
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene.
Arif JM; Smith WA; Gupta RC
Mutat Res; 1997 Aug; 378(1-2):31-9. PubMed ID: 9288883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
